Cargando…
Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer
BACKGROUND: The pathogenesis of human basal-like breast cancer (BLBC) is not well understood and patients with BLBC have a poor prognosis. Expression of the epidermal growth factor receptor (EGFR) and nuclear factor-κB (NF-κB) is well-known to be upregulated in BLBC. The forkhead box C1 (FOXC1) tran...
Autores principales: | Chung, Stacey, Jin, Yanli, Han, Bingchen, Qu, Ying, Gao, Bowen, Giuliano, Armando E., Cui, Xiaojiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477115/ https://www.ncbi.nlm.nih.gov/pubmed/28629477 http://dx.doi.org/10.1186/s12964-017-0180-3 |
Ejemplares similares
-
FOXC1: an emerging marker and therapeutic target for cancer
por: Han, Bingchen, et al.
Publicado: (2017) -
FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort
por: Johnson, Jeff, et al.
Publicado: (2016) -
FOXC1-Induced Non-Canonical WNT5A-MMP7 Signaling Regulates Invasiveness in Triple-Negative Breast Cancer
por: Han, Bingchen, et al.
Publicado: (2017) -
Inhibition of lobuloalveolar development by FOXC1 overexpression in the mouse mammary gland
por: Gao, Bowen, et al.
Publicado: (2017) -
FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance
por: Yu-Rice, Yi, et al.
Publicado: (2016)